100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched
₹122
Our Recommendation
Uriquest 200mg Tablet 10s
4,232+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Muscle spasms of the urinary tract Uriliv Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, frequent, or nighttime urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This medicine starts acting very quickly, within 2 to 3 hours and helps you live a better quality of life. Take it exactly as prescribed by the doctor.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Uriliv Tablet is to be taken with food.
Uriliv Tablet is anti-spasmodic. It works by relaxing muscles of the urinary bladder and prevents frequent, urgent or uncontrolled urination, and relieves associated pain.
Unsafe: Avoid consuming alcohol with Uriliv Tablet as it is deemed unsafe.
Safe when prescribed by an expert: Uriliv Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Safe when prescribed by an expert: Uriliv Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Uriliv Tablet may cause side effects which could affect your ability to drive. You may experience drowsiness, blurred vision or vertigo whilst taking Uriliv Tablet. This may affect your ability to drive.
Caution Advised: Uriliv Tablet should be used with caution in patients with kidney disease. Dose adjustment of Uriliv Tablet may be needed. Doctor consultation is advised.
Seek medical advice from your doctor: There is limited information available on the use of Uriliv Tablet in patients with liver disease. Doctor consultation is advised.
If a dose of Uriliv Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
172B MANIKTALLA MAIN ROAD KOLKATA WB 700054 IN , - , .
Brown JH, Laiken N. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 232
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 547-48
Medscape. Flavoxate (04 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (04 Apr. 2019)
CiplaMed. Flavoxate hydrochloride (26 June 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.